21ST SEPTEMBER 2016, New Jersey- Freyr bags a spot as one of the finalists along others like Merck in CPhI Pharma Awards 2016 for the category: Excellence in Pharma: Regulatory Procedures and Compliance. The event marks as one of the biggest and the most awaited one for the year. Celebrating the best contenders in pharma industry, the event will take place on Tuesday 4th October at Fairmont Rey Juan Carlos.
As a result of Freyr’s notable prowess in the ever-evolving regulatory arena and successful delivery of end-to-end spectrum of Regulatory Solutions and Services to the clients, the industry decision makers at CPhl announced Freyr as one the three finalists in this category.
“Freyr feels accomplished, sharing the nomination list with some of the biggest brands in the industry. It is yet another testimony of all the diligence everyone on board has exhibited to address the needs of our clients with our dependable approaches.” - Suren Dheenadayalan, Co-CEO and Rajiv Rangan, Co-CEO, Freyr.
Freyr exclusively focuses on the entire Regulatory value-chain of Bio-Pharma (Innovators / Generics), Consumer Healthcare and Medical Device companies and is one of the few global companies to have pioneered specialized Centers of Excellence (CoEs) supported by rapidly growing teams of 400+ Regulatory Professionals. For more information, visit http://www.freyrsolutions.com/.
For more details on this release, please contact:
Sana W Patel
+91 - 9100 941 932